This week, Gary, Kate, Henry and Mark discuss a newly approved medication for major depression in adults, initiation of abortive therapy using ubrogepant during migraine prodrome, the value of PCI for patients with stable angina, and a simple intervention to improve communication with hospitalized patients. And a quiz!

This week, Gary, Kate, Henry and Mark discuss a newly approved medication for major depression in adults, initiation of abortive therapy using ubrogepant during migraine prodrome, the value of PCI for patients with stable angina, and a simple intervention to improve communication with hospitalized patients. And a quiz!

Episode 150: EXXUA for depression, ubrogepant for migraine, PCI for stable angina, and a simple way to communications

Four healthily skeptical primary care physicians discuss the latest in primary care medicine. Join Essential Evidence Editor Mark Ebell MD, Rush University's Kate Rowland MD, MSU Professor of Medicine Gary Ferenchick MD, and POEMs co-founder Henry Barry MD, MS for this fast-paced weekly update on evidence-based primary care.

Share Episode 150: EXXUA for depression, ubrogepant for migraine, PCI for stable angina, and a simple way to communications

Sign up to save your podcasts

Episode 150: EXXUA for depression, ubrogepant for migraine, PCI for stable angina, and a simple way to communications

Episode 150: EXXUA for depression, ubrogepant for migraine, PCI for stable angina, and a simple way to communications